Drug & medication recalls Moderate risk

FentaNYL 2 recalled over sterility concerns

Recall date
November 9, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SCA Pharmaceuticals, LLC recalls fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx O…
Recall number
D-0403-2024
FDA classification
Class II
Brand / firm
SCA Pharmaceuticals, LLC
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0202-22, Bar code 70004020022,

Get recall alerts

Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SCA Pharmaceuticals, LLC